Evidence map›Paper›PMID 23044393›Full record

ArticleBiochimica et biophysica acta2013

Sirtuin-4 modulates sensitivity to induction of the mitochondrial permeability transition pore.

Manish Verma, Nataly Shulga, John G Pastorino

RetractedOpen access · greenAbstract readRetracted Publication
In one paragraph

Article in Biochimica et biophysica acta, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Mitochondrial sirtuins in the heart.Heart failure reviews · 2016
    Review
  5. Review
  6. Article
  7. Review
  8. SIRT3 in Cardiac Physiology and Disease.Frontiers in cardiovascular medicine · 2016
    Review
  9. The Tumorigenic Roles of the Cellular REDOX Regulatory Systems.Oxidative medicine and cellular longevity · 2016
    Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Manish VermaDepartment of Molecular Biology, School of Osteopathic Medicine, University of Medicine and Dentistry of New Jersey, Stratford, NJ 08084, USA.
Nataly Shulga
John G Pastorino
Rowan University · US

Funding

Effects of Ethanol TNF Induced CytotoxicityR01AA012897 · NIAAA · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI PASTORINO, JOHN G · 2002 to 2012
$2.3M
Targeting Hexokinase II in ChemotherapyR01CA118356 · NCI · UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED · PI PASTORINO, JOHN G · 2007 to 2012
$1.1M
NCI NIH HHS R01 CA118356NIAAA NIH HHS R01 AA012897
6 · The paper itself

Abstract

The sustained opening of the mitochondrial permeability transition pore (PTP) is a decisive event in the onset of irreversible cell injury. The PTP is modulated by numerous exogenous and endogenous effectors, including mitochondrial membrane potential, ions and metabolites. Mitochondrial sirtuins have recently emerged as pivotal mediators of mitochondrial metabolism. In the present study, we demonstrate that sirt-4 modulates sensitivity to PTP onset induced by calcium and the oxidative cross linking reagent phenylarsine oxide, and PTP dependent cytotoxicity brought about by TNF or doxorubicin. Moreover, the ability of sirt-4 to modulate onset of the PTP is dependent on the expression of glutamate dehydrogenase-1.

Indexed as

ArsenicalsCalciumCell SurvivalCross-Linking ReagentsDoxorubicinGlutamate DehydrogenaseGlutathioneHeLa CellsHumansMembrane Potential, MitochondrialMicroscopy, FluorescenceMitochondriaMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial ProteinsRNA InterferenceArsenicalsCalciumCross-Linking ReagentsDoxorubicinGLUD1 protein, humanGlutamate DehydrogenaseGlutathioneMitochondrial Membrane Transport ProteinsMitochondrial Permeability Transition PoreMitochondrial ProteinsoxophenylarsineSIRT4 protein, humanSirtuinsTumor Necrosis Factor-alpha

Identifiers

PMID23044393
PMCPMC3498821
OpenAlexW2174144627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.